The Polymorphism of SMIM1 Gene in Chinese Dividuals

  • Ying Yu
  • Zhejiong Wang
  • Linchao Zhu
  • Yushiang Lin
  • Haochun Chang
  • Huaxi XuEmail author
Original Article


The SMIM1 gene, which encodes the high-frequency blood group antigen Vel, has not been systematically analyzed at the molecular level in Chinese individuals. To better understand the SMIM1 genetic polymorphism, we assessed mutations among healthy Chinese individuals, patients with red blood cell autoantibodies and hematological disease. A total of 130 patients with hematological disease (case I group), 50 patients with red blood cell autoantibodies (case II group), and 500 healthy controls (control group) were enrolled. Exons 3 and 4 in the SMIM1 gene were sequenced to identify genetic variants or mutations. A polyclonal anti-Vel antibody was used to evaluate the expression of the Vel antigenon red blood cells in patients with novel alleles. The novel alleles of the SMIM1 gene were intron 3 position 193 (TT, CT, CC), 194 (GG, AG), 3′ untranslated region positions 81 (CC, CA) and 87 (AA, CA). The single nucleotide polymorphism (SNP) frequencies of intron 3 position 193 TT, CT, CC were 13.1, 39.2, 47.7% in case group I, 6.7, 33.3, 60.0% in case group II and 8.5, 35.6, 56.2% in the control group, respectively. Other minor allele frequencies were all greater than 10% and all SNPs in Chinese showed Vel antigen expression on RBC membranes. The allele at intron 3 position 193 was the most frequent mutant allele found in the Chinese population and Vel antigen deficiency may not cause problems in Chinese patients with hematological diseases and RBC autoantibodies.


SMIM1 gene Polymorphism Vel antigen Autoantibody 


Compliance With Ethical Standards

Conflict of interest

Ying Yu and Huaxi Xu declares that she has no conflict of interest. Hejiong Wang Linchao Zhu, Yushiang Lin and Haochun Chang declares that she has no conflict of interest.

Ethical Approval

This article does not contain any studies with animals performed by any of the authors.


  1. 1.
    Le Masne A, Vachee A, Horbey C et al (1992) Severe form of neonatal hemolytic disease by anti-Vel allo-immunization. Arch Fr Pediatr 49:899–901Google Scholar
  2. 2.
    Stiller RJ, Lardas O, de Regt RH (1990) Vel isoimmunization in pregnancy. Am J Obstet Gynecol 162:1071–1072CrossRefGoogle Scholar
  3. 3.
    Neppert J, Bartz L, Clasen C (1998) Unsatisfactory detection of an in vivo haemolytic anti-vel by the gel test. Vox Sang 75:70–71CrossRefGoogle Scholar
  4. 4.
    Sussman LN (1962) Current status of the Vel blood group system. Transfusion 2:163–171CrossRefGoogle Scholar
  5. 5.
    Levine P, Robinson EA, Herrington LB et al (1955) Second example of the antibody for the high-incidence blood factor Vel. Am J Clin Pathol 25:751–754CrossRefGoogle Scholar
  6. 6.
    Bradish EB, Shields WF (1959) Another example of anti-Vel. Am J Clin Pathol 31:104–106CrossRefGoogle Scholar
  7. 7.
    Ballif BA, Helias V, Peyrard T et al (2013) Disruption of SMIM1 causes the Vel- blood type. EMBO Mol Med 5:751–761CrossRefGoogle Scholar
  8. 8.
    Olga O, Blumenfeld SKP, Wolfgang H (2016) Alleles of the Vel (SMIM1) blood group system., dbRBC. Last accessed 13 Feb 2016
  9. 9.
    Storry JR, Mallory D (1994) Misidentification of anti-Vel due to inappropriate use of prewarming and adsorption techniques. Immunohematology 10:83–86Google Scholar
  10. 10.
    Cedergren B, Giles CM, Ikin EW (1976) The Vel blood group in northern Sweden. Vox Sang 31:344–355CrossRefGoogle Scholar
  11. 11.
    Herron R, Hyde RD, Hillier SJ (1979) The second example of an anti-vel auto-antibody. Vox Sang 36:179–181CrossRefGoogle Scholar
  12. 12.
    Gale SA, Rowe GP, Northfield FE (1988) Application of a microtitre plate antiglobulin technique to determine the incidence of donors lacking high frequency antigens. Vox Sang 54:172–173CrossRefGoogle Scholar
  13. 13.
    Wang CCH, Yue D, Zhu Z (2007) Rare blood group screening in Shanghai China. Lab Med 22:583–584Google Scholar
  14. 14.
    Liu T, Liu YML, Zhao F, Zhang R, Shi L (2017) Study on screening for Vel-rare blood type by DNA pooling. Chin J Blood Transfus 30:129–132Google Scholar
  15. 15.
    Wang YGS, Dai J, Lu Y, Wu X, Shen W, Lu Q, Xiang D, Cai X (2015) Multiplex PCR for screening Vel, Sc1, GIL, Inb negative rare blood type. Chin J Blood Transfus 28:1000–1003Google Scholar
  16. 16.
    Coghlan G, Zelinski T (2016) The c.64_80del SMIM1 allele is segregating in the Hutterite population. Transfusion 56:946–949CrossRefGoogle Scholar
  17. 17.
    Storry JR, Joud M, Christophersen MK et al (2013) Homozygosity for a null allele of SMIM1 defines the Vel-negative blood group phenotype. Nat Genet 45:537–541CrossRefGoogle Scholar
  18. 18.
    Dezan MR, Dinardo CL, Bosi SR et al (2016) High-throughput strategy for molecular identification of Vel-blood donors employing nucleic acids extracted from plasma pools used for viral nucleic acid test screening. Transfusion 56:1430–1434CrossRefGoogle Scholar
  19. 19.
    Roback JD, Barclay S, Moulds JM et al (2015) A multicenter study on the performance of a fully automated, walk-away high-throughput analyzer for pretransfusion testing in the US population. Transfusion 55:1522–1528CrossRefGoogle Scholar

Copyright information

© Indian Society of Hematology and Blood Transfusion 2018

Authors and Affiliations

  • Ying Yu
    • 1
    • 2
  • Zhejiong Wang
    • 2
  • Linchao Zhu
    • 2
  • Yushiang Lin
    • 3
    • 4
  • Haochun Chang
    • 3
    • 4
  • Huaxi Xu
    • 1
    Email author
  1. 1.Institute of Laboratory Medicine, Jiangsu Key Laboratory of MedicineJiangsu UniversityZhenjiangChina
  2. 2.Department of Laboratory MedicineChinese Medicine Hospital of ZhejiangHangzhouChina
  3. 3.Department of Clinical MedicinePeking University Health Science CenterBeijingChina
  4. 4.College of MedicineAerospace Center HospitalBeijingChina

Personalised recommendations